ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3069

Long Term Follow-up Results of Endovascular Repair in the Management of Arterial Stenosis Caused By Takayasu Arteritis

Aytac Gulcu1, Naciye Sinem Gezer1, Pinar Cetin2, Servet Akar3, Nurullah Akkoc4, Ahmet Yigit Goktay1 and Fatos Onen2, 1Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 2Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 3Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, 4Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: radiology and takayasu arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Takayasu arteritis (TA) is a chronic arteritis of the aorta and its major branches. Patients may require endovascular repair in long term follow up. The aim of this retrospective study was to report our long term follow up results of endovascular repair in the management of arterial stenosis caused by TA.

Materials and Methods: We retrospectively analyzed the outcome of endovascular interventions including angioplasty and angioplasty with stenting in patients with arterial stenosis caused by TA. The patients were followed-up in the Rheumatology out-patient clinic at 3 monthly intervals. Each visit included the evaluation of clinical symptoms, acute-phase reactants and regulation of the medical treatment including glucocorticoids and immunosuppressive drugs. For the evaluation of outcome of the interventional procedure, patients underwent Doppler ultrasonography and MR angiography routinely at every 6 months. Catheter angiography was performed if there was any suspicion of restenosis or occlusion.

Results: This study included 35 patients with TA (31 female, mean age: 42.5 years) who fulfilled the American College of Rheumatology 1990 Criteria for the diagnosis of TA. All patients had symptomatic arterial stenosis proven by catheter angiography. A total of 67 endovascular procedures were performed for 49 arterial stenotic lesions of the patients. Clinical inactivity of the disease was provided with immunosuppressive treatment before any interventions. Treatment of recurrent stenosis by a second endovascular procedure was performed in 11 (22.5%) lesions. The mean follow-up interval after endovascular procedure was 81 months (range 12-144 months). Twenty two (33%) of total 67 endovascular interventions resulted in restenosis or occlusion. Among all 49 arterial lesion, only four (8%) lesions (one common iliac, one renal, one celiac and one thoracic aortic) were occluded at the time of the final evaluation. Kaplan-Meier survival analyses of the renal arterial lesions showed that the overall 1- and 8-year restenosis-free survival rates of renal arterial interventions were 74% and 57%, respectively.

Conclusion: This study suggests that long term patency of TA lesions is related with control of the disease activity by optimal immunosuppressive therapy before and after the initial endovascular procedure. Performing reinterventions with close monitoring of the arterial lesion should not be avoided for better outcomes.


Disclosure: A. Gulcu, None; N. S. Gezer, None; P. Cetin, None; S. Akar, None; N. Akkoc, None; A. Y. Goktay, None; F. Onen, None.

To cite this abstract in AMA style:

Gulcu A, Gezer NS, Cetin P, Akar S, Akkoc N, Goktay AY, Onen F. Long Term Follow-up Results of Endovascular Repair in the Management of Arterial Stenosis Caused By Takayasu Arteritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/long-term-follow-up-results-of-endovascular-repair-in-the-management-of-arterial-stenosis-caused-by-takayasu-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-follow-up-results-of-endovascular-repair-in-the-management-of-arterial-stenosis-caused-by-takayasu-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology